173 related articles for article (PubMed ID: 32111605)
41. The cannabinoid CB
Iyer V; Slivicki RA; Thomaz AC; Crystal JD; Mackie K; Hohmann AG
Eur J Pharmacol; 2020 Nov; 886():173544. PubMed ID: 32896549
[TBL] [Abstract][Full Text] [Related]
42. Importance of sex and relative efficacy at the mu opioid receptor in the development of tolerance and cross-tolerance to the antinociceptive effects of opioids.
Barrett AC; Cook CD; Terner JM; Craft RM; Picker MJ
Psychopharmacology (Berl); 2001 Nov; 158(2):154-64. PubMed ID: 11702089
[TBL] [Abstract][Full Text] [Related]
43. The competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids.
Kest B; McLemore G; Kao B; Inturrisi CE
J Pharmacol Exp Ther; 1997 Dec; 283(3):1249-55. PubMed ID: 9400000
[TBL] [Abstract][Full Text] [Related]
44. Differential tolerance to antinociceptive effects of mu opioids during repeated treatment with etonitazene, morphine, or buprenorphine in rats.
Walker EA; Young AM
Psychopharmacology (Berl); 2001 Mar; 154(2):131-42. PubMed ID: 11314675
[TBL] [Abstract][Full Text] [Related]
45. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
Boronat MA; Olmos G; García-Sevilla JA
Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
[TBL] [Abstract][Full Text] [Related]
46. The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance.
Laulin JP; Maurette P; Corcuff JB; Rivat C; Chauvin M; Simonnet G
Anesth Analg; 2002 May; 94(5):1263-9, table of contents. PubMed ID: 11973202
[TBL] [Abstract][Full Text] [Related]
47. Pharmacological Chaperones Attenuate the Development of Opioid Tolerance.
Okuyama Y; Jin H; Kokubun H; Aoe T
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066035
[TBL] [Abstract][Full Text] [Related]
48. μ-Opioid receptors in primary sensory neurons are essential for opioid analgesic effect on acute and inflammatory pain and opioid-induced hyperalgesia.
Sun J; Chen SR; Chen H; Pan HL
J Physiol; 2019 Mar; 597(6):1661-1675. PubMed ID: 30578671
[TBL] [Abstract][Full Text] [Related]
49. Dopamine D
Rodgers HM; Lim SA; Yow J; Dinkins ML; Patton R; Clemens S; Brewer KL
Pharmacol Biochem Behav; 2020 Jul; 194():172935. PubMed ID: 32335101
[TBL] [Abstract][Full Text] [Related]
50. No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia.
Stein C; Pflüger M; Yassouridis A; Hoelzl J; Lehrberger K; Welte C; Hassan AH
J Clin Invest; 1996 Aug; 98(3):793-9. PubMed ID: 8698872
[TBL] [Abstract][Full Text] [Related]
51. Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer.
Fujioka N; Nguyen J; Chen C; Li Y; Pasrija T; Niehans G; Johnson KN; Gupta V; Kratzke RA; Gupta K
Anesth Analg; 2011 Dec; 113(6):1353-64. PubMed ID: 22003224
[TBL] [Abstract][Full Text] [Related]
52. Effect of crocin on morphine tolerance and serum BDNF levels in a rat model of neuropathic pain.
Safakhah HA; Damghanian F; Bandegi AR; Miladi-Gorji H
Pharmacol Rep; 2020 Apr; 72(2):305-313. PubMed ID: 32112363
[TBL] [Abstract][Full Text] [Related]
53. Blockade of PDGFR-β activation eliminates morphine analgesic tolerance.
Wang Y; Barker K; Shi S; Diaz M; Mo B; Gutstein HB
Nat Med; 2012 Feb; 18(3):385-7. PubMed ID: 22344297
[TBL] [Abstract][Full Text] [Related]
54. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
Pawar M; Kumar P; Sunkaraneni S; Sirohi S; Walker EA; Yoburn BC
Eur J Pharmacol; 2007 Jun; 563(1-3):92-101. PubMed ID: 17349996
[TBL] [Abstract][Full Text] [Related]
55. Effect of metabotropic glutamate 5 receptor antagonists on morphine efficacy and tolerance in rats with neuropathic pain.
Zhou Q; Wang J; Zhang X; Zeng L; Wang L; Jiang W
Eur J Pharmacol; 2013 Oct; 718(1-3):17-23. PubMed ID: 24041921
[TBL] [Abstract][Full Text] [Related]
56. Analgesic tolerance of opioid agonists in mutant mu-opioid receptors expressed in sensory neurons following intrathecal plasmid gene delivery.
Li G; Ma F; Gu Y; Huang LY
Mol Pain; 2013 Dec; 9():63. PubMed ID: 24304623
[TBL] [Abstract][Full Text] [Related]
57. Acute exposure to saccharin reduces morphine analgesia in the the rat: evidence for involvement of N-methyl-D-aspartate and peripheral opioid receptors.
McNally GP; Westbrook RF
Psychopharmacology (Berl); 2000 Mar; 149(1):56-62. PubMed ID: 10789883
[TBL] [Abstract][Full Text] [Related]
58. Axotomy reduces the effect of analgesic opioids yet increases the effect of nociceptin on dorsal root ganglion neurons.
Abdulla FA; Smith PA
J Neurosci; 1998 Dec; 18(23):9685-94. PubMed ID: 9822729
[TBL] [Abstract][Full Text] [Related]
59. Neurophysiological response properties of medullary pain-control neurons following chronic treatment with morphine or oxycodone: modulation by acute ketamine.
Viisanen H; Lilius TO; Sagalajev B; Rauhala P; Kalso E; Pertovaara A
J Neurophysiol; 2020 Sep; 124(3):790-801. PubMed ID: 32755331
[TBL] [Abstract][Full Text] [Related]
60. Repeated low doses of morphine do not induce tolerance but increase the opioid antinociceptive effect in rats with a peripheral neuropathy.
Neil A; Kayser V; Chen YL; Guilbaud G
Brain Res; 1990 Jul; 522(1):140-3. PubMed ID: 2224507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
